DALLAS--(BUSINESS WIRE)--AIS Healthcare, a leading provider of targeted drug delivery and infusion care solutions, announced today that its Targeted Drug Delivery division has been recognized as a 2025 Pioneer in URAC's Leaders in Performance Measurement (LPM) recognition program. This honor is awarded to URAC-accredited organizations who demonstrate leadership in measuring and improving the quality of patient care through performance measurement. The recognition follows URAC's annual review of
AIS Healthcare Targeted Drug Delivery Named 2025 Pioneer in URAC’s Leaders in Performance Measurement Recognition Program
